USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
USA - NYSE:USNA - US90328M1071 - Common Stock
20.26 USD
-5.98 (-22.79%)
20.5 USD
+0.24 (+1.18%)
We assign a fundamental rating of 6 out of 10 to USNA. USNA was compared to 36 industry peers in the Personal Care Products industry. While USNA has a great health rating, its profitability is only average at the moment. USNA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year USNA was profitable.
USNA had a positive operating cash flow in the past year.
Each year in the past 5 years USNA has been profitable.
USNA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of USNA (4.64%) is better than 61.11% of its industry peers.
USNA has a better Return On Equity (6.42%) than 69.44% of its industry peers.
USNA's Return On Invested Capital of 5.38% is in line compared to the rest of the industry. USNA outperforms 58.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USNA is below the industry average of 12.62%.
The last Return On Invested Capital (5.38%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| ROIC | 5.38% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
USNA has a better Profit Margin (3.79%) than 66.67% of its industry peers.
USNA's Profit Margin has declined in the last couple of years.
USNA's Operating Margin of 6.25% is fine compared to the rest of the industry. USNA outperforms 61.11% of its industry peers.
USNA's Operating Margin has declined in the last couple of years.
USNA has a better Gross Margin (79.93%) than 94.44% of its industry peers.
In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.25% | ||
| PM (TTM) | 3.79% | ||
| GM | 79.93% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
USNA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, USNA has less shares outstanding
USNA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for USNA is higher compared to a year ago.
2.2 Solvency
USNA has an Altman-Z score of 4.02. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
USNA has a better Altman-Z score (4.02) than 69.44% of its industry peers.
There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.02 |
ROIC/WACC0.64
WACC8.43%
2.3 Liquidity
USNA has a Current Ratio of 2.15. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
USNA has a Current ratio (2.15) which is comparable to the rest of the industry.
A Quick Ratio of 1.47 indicates that USNA should not have too much problems paying its short term obligations.
USNA's Quick ratio of 1.47 is fine compared to the rest of the industry. USNA outperforms 63.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.47 |
3. Growth
3.1 Past
USNA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.64%.
Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.07% on average per year.
The Revenue has been growing slightly by 2.75% in the past year.
The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-6.64%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%37.04%
Revenue 1Y (TTM)2.75%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%10.87%
3.2 Future
Based on estimates for the next years, USNA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.49% on average per year.
USNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.12% yearly.
EPS Next Y2.78%
EPS Next 2Y15.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.33%
Revenue Next 2Y10.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
USNA is valuated cheaply with a Price/Earnings ratio of 7.59.
Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.02, USNA is valued rather cheaply.
A Price/Forward Earnings ratio of 5.84 indicates a rather cheap valuation of USNA.
Based on the Price/Forward Earnings ratio, USNA is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
USNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.59 | ||
| Fwd PE | 5.84 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 97.22% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.59 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USNA does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of USNA may justify a higher PE ratio.
A more expensive valuation may be justified as USNA's earnings are expected to grow with 15.49% in the coming years.
PEG (NY)2.72
PEG (5Y)N/A
EPS Next 2Y15.49%
EPS Next 3YN/A
5. Dividend
5.1 Amount
USNA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
20.26
-5.98 (-22.79%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners61.34%
Inst Owner Change0%
Ins Owners0.61%
Ins Owner Change-0.04%
Market Cap370.15M
Analysts43.33
Price Target62.22 (207.11%)
Short Float %6.55%
Short Ratio5.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.3%
Min EPS beat(2)2.24%
Max EPS beat(2)34.35%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)2.24%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)17.25%
EPS beat(12)9
Avg EPS beat(12)21.2%
EPS beat(16)10
Avg EPS beat(16)13.82%
Revenue beat(2)2
Avg Revenue beat(2)1.7%
Min Revenue beat(2)0.66%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.39%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)9
Avg Revenue beat(16)-0.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.59 | ||
| Fwd PE | 5.84 | ||
| P/S | 0.41 | ||
| P/FCF | N/A | ||
| P/OCF | 5.87 | ||
| P/B | 0.7 | ||
| P/tB | 1.52 | ||
| EV/EBITDA | 3.59 |
EPS(TTM)2.67
EY13.18%
EPS(NY)3.47
Fwd EY17.12%
FCF(TTM)-8.34
FCFYN/A
OCF(TTM)3.45
OCFY17.03%
SpS49.22
BVpS29.07
TBVpS13.36
PEG (NY)2.72
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| ROCE | 9.17% | ||
| ROIC | 5.38% | ||
| ROICexc | 7.14% | ||
| ROICexgc | 18.89% | ||
| OM | 6.25% | ||
| PM (TTM) | 3.79% | ||
| GM | 79.93% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexcg growth 3Y-27.3%
ROICexcg growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 613.46% | ||
| Cap/Sales | 23.95% | ||
| Interest Coverage | 84.38 | ||
| Cash Conversion | 69.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.47 | ||
| Altman-Z | 4.02 |
F-Score5
WACC8.43%
ROIC/WACC0.64
Cap/Depr(3y)385.75%
Cap/Depr(5y)273.18%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%37.04%
EPS Next Y2.78%
EPS Next 2Y15.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.75%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%10.87%
Revenue Next Year12.33%
Revenue Next 2Y10.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.36%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year56.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-291.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.5%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%